Clinical Endoscopy

Original Article

Epidemiology of early esophageal adenocarcinoma: Thuy-Van P. Hang, Zachary Spiritos, Anthony M. Gamboa, Zhengjia Chen, Seth Force, Vaishali Patel, Saurabh Chawla, Steven Keilin, Nabil F. Saba, Bassel El-Rayes, Qiang Cai, Field F. Willingham; Clin Endosc 2022;55(3):372-380. Published online February 11, 2022; DOI: https://doi.org/10.5946/ce.2021.152

Background
/Aims: Endoscopic resection has become the preferred treatment approach for select early esophageal adenocarcinoma (EAC); however, the epidemiology of early stage disease has not been well defined.
Methods
Surveillance Epidemiology and End Results (SEER) data were analyzed to determine age-adjusted incidence rates among major epithelial carcinomas, including EAC, from 1973 to 2017. The percent change in incidence over time was compared according to tumor subtype. Early T-stage, node-negative EAC without metastasis was examined from 2004 to 2017 when precise T-stage data were available.
Results
The percent change in annual incidence from 1973 to 2017 was 767% for EAC. Joinpoint analysis showed that the average annual percent change in EAC from 1973 to 2017 was 5.11% (95% confidence interval, 4.66%–5.56%). The annual percent change appeared to plateau between 2004 and 2017; however, early EAC decreased from 2010 to 2017, with an annual percent change of -5.78%.
Conclusions
There has been a 7-fold increase in the incidence of EAC, which was significantly greater than that of the other major epithelial malignancies examined. More recently, the incidence of early EAC has been decreasing. Approximately one in five patients has node negative, potentially resectable early stage disease.

Citations

Citations to this article as recorded by

Predictors of Understaging with EUS and PET-CECT in Early Esophageal Carcinoma
Karthik Venkataramani, Sabita Jiwnani, Devayani Niyogi, Virendrakumar Tiwari, C. S. Pramesh, George Karimundackal
Journal of Gastrointestinal Cancer.2025;[Epub] CrossRef
Pyrotinib monotherapy for advanced HER2-positive esophageal adenocarcinoma with trastuzumab resistance and chemotherapy intolerance: a case report and literature review
Tao Wang, Mingyuan He, Wei Guan
Discover Oncology.2025;[Epub] CrossRef
Histology Shift in Esophageal Cancer Between Biopsies and Resections After Neoadjuvant Therapy: A Pilot Study
Tieying Hou, Zhaohai Yang, Qingzhao Zhang, Xuchen Zhang, Xiaoyan Liao, Jingmei Lin
International Journal of Surgical Pathology.2024; 32(5): 920. CrossRef
Concise Commentary: It’s All Downhill from Here—How Diagnostic and Therapeutic Advances May Decrease the Incidence Rates of Gastroesophageal Junction and Esophageal Adenocarcinoma
Anthony Gamboa, Rishi Naik
Digestive Diseases and Sciences.2024; 69(1): 254. CrossRef
Descriptive Epidemiology of Early-Onset Gastrointestinal Cancers in Iran, 2014-2018
Mohammad Sadra Gholami Chahkand, Fatemeh Esmaeilpour Moallem, Fatemeh Ghasemi-Kebria, Reza Malekzadeh, Gholamreza Roshandel, Mohammad Taher
Middle East Journal of Digestive Diseases.2024; 16(1): 28. CrossRef
A Systematic Review and Meta-analysis of the Relationship between Statin Intake and Esophageal Cancer
Armin Khaghani, Karamali Kasiri, Saeid Heidari-Soureshjani, Catherine M.T. Sherwin, Hossein Mardani-Nafchi
Anti-Cancer Agents in Medicinal Chemistry.2024; 24(14): 1029. CrossRef
Long-term outcomes of endoscopic submucosal dissection for early esophageal adenocarcinoma in the Eastern population: a comprehensive analysis
Xiao-han Jiang, Qing Liu, Min Fu, Cheng-fan Wang, Rui-han Zou, Li Liu, Min Wang
Journal of Gastrointestinal Surgery.2024; 28(12): 1988. CrossRef
Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma
Md Sazzad Hassan, Chloe Johnson, Saisantosh Ponna, Dimitri Scofield, Niranjan Awasthi, Urs von Holzen
Cancers.2024; 16(18): 3175. CrossRef
Epidemiologie der Adenokarzinome des Ösophagus und des ösophagogastralen Übergangs
Sabine Luttmann, Andrea Eberle, Joachim Hübner
Die Onkologie.2023; 29(6): 470. CrossRef
Evaluation of Esophageal Dysphagia in Elderly Patients
Khanh Hoang Nicholas Le, Eric E. Low, Rena Yadlapati
Current Gastroenterology Reports.2023; 25(7): 146. CrossRef
Molecular Biology and Clinical Management of Esophageal Adenocarcinoma
Shulin Li, Sanne Johanna Maria Hoefnagel, Kausilia Krishnawatie Krishnadath
Cancers.2023; 15(22): 5410. CrossRef
Progress in Clinical Management of Esophago-Jejunal Anastomotic Fistula with Total Gastrectomy for Adenocarcinoma of the Esophagogastric Junction
天伟赖
Advances in Clinical Medicine.2023; 13(11): 17210. CrossRef
Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model
Yun Zhang, Katherine M. Weh, Bridget A. Tripp, Jennifer L. Clarke, Connor L. Howard, Shruthi Sunilkumar, Amy B. Howell, Laura A. Kresty
Pharmaceuticals.2023; 16(12): 1697. CrossRef
Lessons learned in clinical epidemiology of esophageal adenocarcinoma
Hye Kyung Jung
Clinical Endoscopy.2022; 55(3): 365. CrossRef

6,375 View
289 Download
9 Web of Science
14 Crossref

Case Report

Long -Term Survival in Stage IV Esophageal Adenocarcinoma with Chemoradiation and Serial Endoscopic Cryoablation: Zachary Spiritos, Parit Mekaroonkamol, Bassel F. El- Rayes, Seth D. Force, Steven A. Keilin, Qiang Cai, Field F. Willingham; Clin Endosc 2017;50(5):491-494. Published online April 24, 2017; DOI: https://doi.org/10.5946/ce.2017.006

Abstract PDF PubReader ePub

Esophageal cancer has a poor overall prognosis and is frequently diagnosed at a late stage. Conventional treatment for metastatic esophageal cancer involves chemotherapy and radiation. Local disease control plays a significant role in improving survival. Endoscopic spray cryotherapy is a novel modality that involves freezing and thawing to produce local ablation of malignant tissue via ischemic mechanisms. Spray cryotherapy has been shown to be effective, particularly for early T-stage, superficial esophageal adenocarcinomas. We present the case of a 72-year-old-male with locally recurrent stage IV esophageal adenocarcinoma and long-term survival of 7 years to date, with concurrent chemoradiation and serial cryoablation. He remains asymptomatic and continues to undergo chemotherapy and sequential cryoablation. The findings highlight the long-term safety and efficacy of cryotherapy in combination with chemoradiation, and suggest that cryoablation may have an additive role in the treatment of advanced stage esophageal adenocarcinoma.

Citations

Citations to this article as recorded by

Endoscopic Palliative Therapies for Esophageal Cancer
Youssef Y. Soliman, Madappa Kundranda, Toufic Kachaamy
Gastrointestinal Endoscopy Clinics of North America.2024; 34(1): 91. CrossRef
Role of oesophageal balloon cryoablation in combination with personalised immunotherapy to achieve luminal control in metastatic oesophageal cancer: a case report
Benjamin Charles Norton, Apostolis Papaefthymiou, Andrea Telese, Margaret Duku, Imran Chaudhry, Alberto Murino, Gavin Johnson, Charles Murray, Rehan Haidry
Frontline Gastroenterology.2024; 15(4): 336. CrossRef
Cryoballoon ablation as salvage therapy after nonradical resection of a high-risk T1b esophageal adenocarcinoma: a case report
Charlotte N. Frederiks, Jolanda M.W. van de Water, Gati Ebrahimi, Bas L.A.M. Weusten
European Journal of Gastroenterology & Hepatology.2022; 34(3): 354. CrossRef
Surgery to the primary tumor is associated with improved survival of patients with metastatic esophageal cancer: propensity score-matched analyses of a large retrospective cohort
Rui Zhang, Jiahua Zou, Ping Li, Qin Li, Yunfeng Qiao, Jianglong Han, Kejie Huang, Peng Ruan, Huiqing Lin, Qibin Song, Zhenming Fu
Diseases of the Esophagus.2019;[Epub] CrossRef

8,475 View
139 Download
3 Web of Science
4 Crossref

First
Prev
Page of 1
Next
Last

Search